Immupharma is headquartered in London, GB
Immupharma Office Locations
Immupharma has offices in London, Mulhouse and Sarnen
London, GB (HQ)
50 Broadway
Sarnen, CH
10 Poststrasse
Mulhouse, FR
5 Rue du Rhône
Immupharma Financials and Metrics
Immupharma Financials
Immupharma's revenue was reported to be £164.8 k in FY, 2016 which is a 116% increase from the previous period.
GBP
Revenue (FY, 2016) | 164.8 k |
Net income (FY, 2016) | (5.3 m) |
EBITDA (FY, 2016) | (6.5 m) |
EBIT (FY, 2016) | (6.6 m) |
Market capitalization (20-Oct-2017) | 127.6 m |
Closing share price (20-Oct-2017) | 1 |
Cash (31-Dec-2016) | 1.9 m |
Immupharma's current market capitalization is £127.6 m.
| GBP | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 63.2 k | 57.1 k | 22.1 m | 32.5 k | 16.8 k | 184.8 k | 76.4 k | 164.8 k | ||
Revenue growth, % | (59%) | |||||||||
Operating expense total | 3.6 m | 4.6 m | 11.8 m | 4.2 m | (3.8 m) | 3.6 m | 4.6 m | 6.8 m | ||
EBITDA | (3.5 m) | (4.5 m) | 10.3 m | (4.1 m) | 3.9 m | (4.1 m) | (4.2 m) | (3.3 m) | (4.4 m) | (6.5 m) |
| GBP | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Cash | 2.9 m | 12.5 m | 22.5 m | 15.6 m | 12.2 m | 8.9 m | 5.4 m | 5.4 m | 833.4 k | 1.9 m |
Accounts Receivable | 3.2 k | 22.2 k | 2.8 k | 13.2 k | ||||||
Current Assets | 3.3 m | 12.6 m | 23.9 m | 16.8 m | 13.5 m | 9.8 m | 6.5 m | 6.1 m | 2.4 m | 6 m |
PP&E | 12.8 k | 13.3 k | 9.3 k | 76.8 k | 125.4 k | 114.8 k | 97.1 k | 366.4 k | 280.1 k | 231.9 k |
| GBP | FY, 2007 | FY, 2008 | FY, 2009 | FY, 2010 | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (3.1 m) | 4.7 m | 8.1 m | (2 m) | (3.4 m) | (3.8 m) | (3.7 m) | (2.9 m) | (3.9 m) | (5.3 m) |
Cash From Operating Activities | 3.8 m | (3.6 m) | 12 m | (6.8 m) | (3.4 m) | (3.3 m) | (3.9 m) | (2.5 m) | (4.1 m) | (6.5 m) |
Cash From Financing Activities | (77.6 k) | 12 m | (143.5 k) | 555.2 k | 165.3 k | 356.9 k | 191.5 k | 3 m | (310.1 k) | 7.4 m |
Net Change in Cash | 3.7 m | 8.5 m | 11.9 m | (6.4 m) | (3.2 m) | (2.8 m) | (3.7 m) | 199 k | (4.5 m) | 896.3 k |
| Y, 2016 | |
|---|---|
Financial Leverage | 1.2 x |
